<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[CBN Agents and Diseases]]></title><link>http://www.upmc-biosecurity.org/</link><description><![CDATA[Clinicians' Biosecurity Network Report archive for biosecurity agents and diseases.]]></description><copyright><![CDATA[Copyright © 2010. University of Pittsburgh Medical Center. All rights reserved.]]></copyright><managingEditor><![CDATA[cbn_editor@upmc-biosecurity.org]]></managingEditor><webmaster><![CDATA[cbn_editor@upmc-biosecurity.org]]></webmaster><lastBuildDate>Fri, 22 Jan 2010 15:55:36 GMT</lastBuildDate><generator>SiteExecutive v4.1</generator><item><title><![CDATA[Anthrax Cases Among Heroin Users in Europe Illustrate Novel Risk (01-22-2010)]]></title><link>http://www.upmc-cbn.org/report_archive/2010/01Jan_2010/cbnreport_01222010.html</link><description><![CDATA[Bacillus anthracis, a ubiquitous but deadly pathogen found in soil, has been primarily an occupational disease, with some exceptions. Recent cases of anthrax, some fatal, in Scotland and Germany highlight a new risk--recreational heroin use.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2010/01Jan_2010/cbnreport_01222010.html</guid><pubDate>Fri, 22 Jan 2010 15:49:15 GMT</pubDate></item><item><title><![CDATA[Unusual Case of GI Anthrax in New Hampshire Raises Questions (01-08-2010)]]></title><link>http://www.upmc-cbn.org/report_archive/2010/01Jan_2010/cbnreport_01082010.html</link><description><![CDATA[On December 26, 2009, the New Hampshire Department of Health and Human Services announced that a female member of a drumming group was diagnosed with gastrointestinal anthrax, presumably contracted at an event held on December 4.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2010/01Jan_2010/cbnreport_01082010.html</guid><pubDate>Fri, 08 Jan 2010 12:14:40 GMT</pubDate></item><item><title><![CDATA[Adenovirus 14: An Emerging Threat (04-17-2009)]]></title><link>http://www.upmc-cbn.org/report_archive/2009/04_April_2009/cbnreport_04172009.html</link><description><![CDATA[The Journal of Infectious Disease has just published 2 papers by teams of researchers describing separate, severe outbreaks of Adenovirus 14 (Ad14), a historically rare serotype of adenovirus that has not been known to cause severe disease.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2009/04_April_2009/cbnreport_04172009.html</guid><pubDate>Fri, 17 Apr 2009 15:42:36 GMT</pubDate></item><item><title><![CDATA[3rd Generation Smallpox Vaccine LC16m8 Proved Safe and Immunogenic (03-20-2009)]]></title><link>http://www.upmc-cbn.org/report_archive/2009/03_March_2009/cbnreport_03202009.html</link><description><![CDATA[New JAMA study from Japanese researchers testing LC16m8,  tissue-cultured 3rd gen smallpox vaccine. Overall, the vaccine displayed high levels of vaccine take in primary vaccinees and provoked an effective booster response in some revaccinees.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2009/03_March_2009/cbnreport_03202009.html</guid><pubDate>Fri, 20 Mar 2009 14:31:31 GMT</pubDate></item><item><title><![CDATA[Longer Treatment Window for Botulism (02-20-2009)]]></title><link>http://www.upmc-cbn.org/report_archive/2009/02_February_2009/cbnreport_02202009.html</link><description><![CDATA[Results from a new study published in JID demonstrate the persistence of botulinum toxin in the serum of patients up to 11 days after exposure. The prolonged persistence of toxin allows for admin of anti-toxin as long 12 days after toxin ingestion]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2009/02_February_2009/cbnreport_02202009.html</guid><pubDate>Fri, 20 Feb 2009 18:53:50 GMT</pubDate></item><item><title><![CDATA[Update on Smallpox Vaccine (01-08-2009)]]></title><link>http://www.upmc-cbn.org/report_archive/2009/01_January_2009/cbnreport_01092009.html</link><description><![CDATA[The 2001 anthrax attacks spurred new vaccine development, and, as a result, there have been several updates to the smallpox vaccine armamentarium, which are reviewed here.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2009/01_January_2009/cbnreport_01092009.html</guid><pubDate>Fri, 09 Jan 2009 14:42:32 GMT</pubDate></item><item><title><![CDATA[Long-lived Immunity after Smallpox Vaccination (12-05-2008)]]></title><link>http://www.upmc-cbn.org/report_archive/2008/12_December_2008/cbnreport_12052008.html</link><description><![CDATA[Researchers from NIA have just reported results of a study in which 97% of 209 vaccinated subjects maintained antibody titers for up to 88 years.  While promising, these results must be interpreted carefully.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2008/12_December_2008/cbnreport_12052008.html</guid><pubDate>Fri, 05 Dec 2008 15:05:41 GMT</pubDate></item><item><title><![CDATA[New Arenavirus Identified as Cause of Cluster of Illness and Death in South Africa and Zambia (11-07-2008)]]></title><link>http://www.upmc-cbn.org/report_archive/2008/11_November_2008/cbnreport_11072008.html</link><description><![CDATA[Through molecular diagnostic techniques, a previously unknown arenavirus has been identified as the etiologic agent responsible for 4 deaths in Africa that occurred in September and October of 2008.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2008/11_November_2008/cbnreport_11072008.html</guid><pubDate>Fri, 07 Nov 2008 21:12:16 GMT</pubDate></item><item><title><![CDATA[Ten Notable Publications of 2007 (01-10-2008)]]></title><link>http://www.upmc-cbn.org/report_archive/2008/01_January_2008/cbnreport_01102008.html</link><description><![CDATA[Ten notable publications of 2007 from Center for Biosecurity of UPMC.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2008/01_January_2008/cbnreport_01102008.html</guid><pubDate>Thu, 10 Jan 2008 22:08:00 GMT</pubDate></item><item><title><![CDATA[HHS Award Multiple Contracts for Anthrax Countermeasures (09-28-2007)]]></title><link>http://www.upmc-cbn.org/report_archive/2007/09_September_2007/cbnreport_09282007.html</link><description><![CDATA[CBN Report: BARDA awarded contracts for advanced development of anthrax countermeasures Anthim and Valortim. BARDA also awarded a purchase contract for BioThrax anthrax vaccine.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2007/09_September_2007/cbnreport_09282007.html</guid><pubDate>Mon, 01 Oct 2007 14:32:31 GMT</pubDate></item><item><title><![CDATA[The Potential Disaster of Extensively Drug Resistant Tuberculosis (11-10-2006)]]></title><link>http://www.upmc-cbn.org/report_archive/2006/11_November_2006/cbnreport_111006.html</link><description><![CDATA[At the recent meeting of the IDSA in Toronto (October 12-15, 2006), Dr. Henry Blumberg of the Emory University School of Medicine presented a comprehensive review of tuberculosis in the world. The picture is grim.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2006/11_November_2006/cbnreport_111006.html</guid><pubDate>Fri, 10 Nov 2006 15:43:00 GMT</pubDate></item><item><title><![CDATA[Smallpox Antiviral Effective in Animal Trials (10-23-2006)]]></title><link>http://www.upmc-cbn.org/report_archive/2006/10_October_2006/cbnreport_102306.html</link><description><![CDATA[On October 18, 2006, SIGA Technologies, Inc. announced that its antiviral drug candidate SIGA-246 demonstrated a high degree of protection against variola, the smallpox virus, in a primate trial conducted at the CDC.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2006/10_October_2006/cbnreport_102306.html</guid><pubDate>Mon, 23 Oct 2006 21:15:00 GMT</pubDate></item></channel></rss>
